Hepatitis Monthly
Official Journal of Research Center for Gastroenterology and Liver Diseases
Scopus by Title (Ref)
1. Current Advances in Hepatocellular Carcinoma: Transition from: Traditional to Advanced Technology
- Gautam S. , et al.
2. Angiogenesis Is Associated With Aggressive Biology That Counterbalances With Tumor Immunogenicity in Hepatocellular Carcinoma
- Vaghjiani R. , et al.
3. Clinical effect analysis of different regimens of capecitabine in the treatment of patients with advanced colon cancer
- Ju F. , et al.
4. Efficacy and Safety of Metronomic Capecitabine in Hepatocellular Carcinoma: A Systematic Review and Meta-analysis
- Gupta N. , et al.
5. BCL11B expression in hepatocellular carcinoma relates to chemosensitivity and clinical prognosis
- Abe H. , et al.
8. RMI2 is a prognostic biomarker and promotes tumor growth in hepatocellular carcinoma
- Li Y. , et al.
9. An Overview of the Synthetic Route to the Marketed Formulations of Pyrimidine: A Review
- Kumar A. , et al.
10. Case Report: Durable Response to Very Low Dose Tyrosine Kinase Inhibitors in Advanced Hepatocellular Carcinoma
- Tang T.Y. , et al.
11. Capecitabine Treatment: A Safe and Effective Therapy in the Field of Oncology
- Beenet L. , et al.
12. CISD2 Promotes Resistance to Sorafenib-Induced Ferroptosis by Regulating Autophagy in Hepatocellular Carcinoma
- Li B. , et al.
13. Systemic therapies in elderly patients with advanced hepatocellular carcinoma: Do not forget metronomic capecitabine
- Wilhelmi M. , et al.
14. Systemic therapies in elderly patients with advanced hepatocellular carcinoma: do not forget metronomic capecitabine
- Kapacee Z.A. , et al.
15. Ramucirumab and other new systemic therapies for hepatocellular carcinoma: Still uncovered the problem of Child-Pugh B patients
- Wilhelmi M. , et al.
16. Novel ferrocene derivatives induce G0/G1 cell cycle arrest and apoptosis through the mitochondrial pathway in human hepatocellular carcinoma
- Zheng J. , et al.
17. Gene Polymorphism of MUC15, MMP14, BRAF, and COL1A1 Is Associated with Capsule Formation in Hepatocellular Carcinoma
- Sun W. , et al.
18. Global analysis of gene expression signature and diagnostic/prognostic biomarker identification of hepatocellular carcinoma
- Wang J. , et al.
19. The Effect of Ferroptosis-Related Genes on Prognosis and Tumor Mutational Burden in Hepatocellular Carcinoma
- Zhang H. , et al.
20. A New CYP2E1 Inhibitor, 12-Imidazolyl-1-dodecanol, Represents a Potential Treatment for Hepatocellular Carcinoma
- Diesinger T. , et al.
21. Upregulation of Nei-Like DNA Glycosylase 3 Predicts Poor Prognosis in Hepatocellular Carcinoma
- Wu D. , et al.
22. Curative effect of endostar combined with oxaliplatin in the treatment of primary hepatic carcinoma and its influence on immune cells
- Lei C. , et al.
23. Immunotherapy in hepatocellular carcinoma
- Buonaguro L. , et al.
24. Potentiating cancer vaccine efficacy in liver cancer
- Tagliamonte M. , et al.